Previous Close | 7.65 |
Open | 7.67 |
Bid | 1.70 |
Ask | 5.00 |
Strike | 42.50 |
Expire Date | 2024-09-20 |
Day's Range | 7.65 - 7.67 |
Contract Range | N/A |
Volume | |
Open Interest | 92 |
Staar Surgical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 87.
Staar Surgical (STAA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
LAKE FOREST, Calif., June 05, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Williams, Chief Financial Officer, at the upcoming Goldman Sachs 45th Annual Global Healthcare Conference, which will be held in Miami, Florida.